Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
VistaGen Therapeutics, Inc. (VTGN) had Income from Continuous Operations of $-15.10M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.24M |
|
$-15.10M |
|
-- |
|
$0.24M |
|
$16.05M |
|
$-15.80M |
|
$0.71M |
|
$-15.10M |
|
$-15.10M |
|
$-15.10M |
|
|
Income from Continuous Operations |
$-15.10M |
$-15.10M |
|
$-15.10M |
|
$-15.80M |
|
$-15.89M |
|
31.93M |
|
31.93M |
|
$-0.47 |
|
$-0.47 |
|
| Balance Sheet Financials | |
$66.72M |
|
$0.53M |
|
$2.21M |
|
$68.92M |
|
$11.15M |
|
-- |
|
$1.00M |
|
$12.16M |
|
$56.77M |
|
$56.77M |
|
$56.77M |
|
29.28M |
|
| Cash Flow Statement Financials | |
$-18.85M |
|
$-0.79M |
|
$1.49M |
|
$67.13M |
|
$48.98M |
|
$-18.15M |
|
$0.92M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.98 |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
100.00% |
|
-6477.05% |
|
-6477.05% |
|
-- |
|
-6186.48% |
|
-6186.48% |
|
$-18.91M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-26.59% |
|
-26.59% |
|
-21.90% |
|
-26.59% |
|
$1.94 |
|
$-0.59 |
|
$-0.59 |
|